Cargando…
Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic
OBJECTIVE: Patients with rheumatic diseases such as rheumatoid arthritis (RA) and lupus have increased risk of infection and are treated with medications that may increase this risk yet are also hypothesized to help treat COVID‐19. We set out to understand how the COVID‐19 pandemic has impacted the...
Autores principales: | Michaud, Kaleb, Wipfler, Kristin, Shaw, Yomei, Simon, Teresa A., Cornish, Adam, England, Bryant R., Ogdie, Alexis, Katz, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7264613/ https://www.ncbi.nlm.nih.gov/pubmed/32311836 http://dx.doi.org/10.1002/acr2.11148 |
Ejemplares similares
-
Rheumatic disease patient decision-making about COVID-19 vaccination: a qualitative analysis
por: Shaw, Yomei P., et al.
Publicado: (2022) -
Probiotic Use and Psoriatic Arthritis Disease Activity
por: Grinnell, Madison, et al.
Publicado: (2020) -
Side Effects of Methotrexate and Tumor Necrosis Factor Inhibitors: Differences in Tolerability Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis
por: Ogdie, Alexis, et al.
Publicado: (2022) -
Perspectives on Treatment Burden for Methotrexate and Tumor Necrosis Factor Inhibitors Among Patients With Psoriatic Arthritis and Rheumatoid Arthritis: A Qualitative Study
por: Ogdie, Alexis, et al.
Publicado: (2023) -
Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases
por: Gabriel, Sherine E, et al.
Publicado: (2009)